Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The trial is a phase III, non-inferiority, observer-blind, randomised, active controlled, multicentre clinical trial with 2 parallel groups: IPV-Al SSI (investigational vaccine) and IPV SSI (comparator vaccine). The vaccines will be administered at 2, 4 and 6 months of age.
Epistemonikos ID: 382ee435dce7b15df2692f67f3b6995da7d68ecf
First added on: May 20, 2024